UNSPSC 51332303: Neflumozide

This classification denotes a dopamine antagonist with the molecular formula C22H23FN4O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SU2C8RYO3O, chemically known as 1-(1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-piperidyl)-3h-benzimidazol-2(1h)-one hydrochloride but generally known as neflumozide hydrochloride, which bears US NIH Compound Identifier 55463. Most nations schedule neflumozide under HS 29349990 and SITC 51579. As of Q4 2014, NEFLUMOZIDE remains the US FDA Preferred Term for this commodity.

Neflumozide bears US NLM identifiers UMLS ID C2827279 and NCI Concept Code C83992. SMILES: C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC4=NOC5=C4C=CC(=C5)F.Cl.

UNSPSC 51332303 Neflumozide, a Commodity code, covers pharmaceutical products and medical supplies procured by state and local health agencies and departments, though the recent activity block shows solicitation under this code for naloxone and drug deactivation systems rather than neflumozide itself. State and local governments buy emergency response pharmaceuticals and harm-reduction supplies under this code to support public health initiatives, community health programs, and substance-abuse response efforts. Issuing bodies include county health departments and community health agencies operating public health facilities.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries an initial two-year term with a one-year renewal option and includes standard compliance requirements such as drug-free workplace certification, E-Verify enrollment, and insurance coverage. The recent-opportunities block reflects only a single identifiable solicitation under this code in the timeframe reviewed, with activity centered in Florida. Geographic concentration and issuing-body frequency cannot be characterized beyond the single Seminole County procurement from the available data.